A sweeping new personnel rule finalized by the Biden administration will reclassify up to 50,000 senior federal employees in policy-influencing roles, stripping them of traditional job protections and moving them to an 'at-will' employment status akin to the private sector.
The Office of Personnel Management is assessing the $2.5 million program designed to monitor racial discrimination at polls, as its future funding hangs in the balance ahead of the midterm elections.
As investors pivot from large-cap tech, Asia's small-cap and value sectors offer resilient growth stories. We analyze three companies—from networking hardware to biotech and regional banking—that combine strong fundamentals with untapped potential.
As Asian tech markets navigate a period of global uncertainty and shifting capital flows, a select group of companies are demonstrating resilience and explosive growth potential. We analyze three standout contenders from healthcare AI to biotech and smart infrastructure, examining their strategies to thrive in a complex investment landscape.
A looming partial government shutdown highlights critical nuances in prediction market contracts, with Polymarket and Kalshi odds soaring as procedural delays in Congress turn betting specifics into the central story.
The Biden administration is reviewing a decades-old program that dispatches neutral federal observers to polling places to prevent voter discrimination, with potential defunding on the table ahead of the midterms.
As global investors pivot towards value, a deep dive into Asian markets reveals several companies trading significantly below their estimated intrinsic worth, offering potential opportunities for discerning investors.
While burning cash, the gene therapy developer Benitec Biopharma holds a substantial war chest. With a decade-long cash runway and a path to breakeven, the market's focus shifts to its clinical pipeline rather than immediate profitability.
Amidst a complex market landscape, select Asian companies with high insider ownership are signaling strong growth trajectories. We examine three firms—InnoScience, OPM Biosciences, and Wuhan Jingce—where leadership's skin in the game aligns with robust earnings forecasts.
Amidst a resilient European market backdrop, dividend-paying stocks are drawing investor attention for their potential to deliver income and stability. We examine three companies offering compelling yields.
Fox News Digital has obtained an internal email revealing a now-retired FBI agent's push in 2025 to investigate Elon Musk's official communications via X, comparing the practice to Hillary Clinton's private email server. The probe was never opened, and the agent is no longer with the Bureau.
